Lightnews — Scholar-powered news

Angela Cochran @acochran12733.bsky.social · 17d

JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social

JCO Journals @jco-asco.bsky.social · 21d

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

2 5

Angela Cochran @acochran12733.bsky.social · Sep 5

Oh, I agree that the hammer could have fallen at any point. I do think that new pressures on Google in the search area raise the question a little more acutely.

2

Angela Cochran @acochran12733.bsky.social · Sep 5

Might Google Scholar be headed to the Google Graveyard? hannahshelley.neocities.org/blog/2025_08...

Google Scholar Is Doomed

Academia built entire careers on a free Google service with zero guarantees. What could go wrong?

hannahshelley.neocities.org

2 1

Angela Cochran @acochran12733.bsky.social · Aug 5

Can't be, Paul. Schools are gun-free zones and the NRA/GOP is constantly telling us that this makes them LESS safe.

1 2

Reposted by Angela Cochran

Stacey Tinianov, MPH @coffeemommy.bsky.social · Jul 28

A pleasure and an honor to join @fumikochino.bsky.social & Dr. Ethan Ludmir in this @ascocancer.bsky.social conversation on incomplete reporting and toxicity- minimizing language in oncology! 💗

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · Jul 21

“When choosing cancer therapies, people should not have to choose between being alive & living”

Toxicity minimizing language ("safe” & “tolerable”) are subjective & can downplay QOL limiting side effects from treatment.

🚨New @ascocancer.bsky.social Podcast is live today!
@coffeemommy.bsky.social

Incomplete Reporting and Toxicity-Minimizing Language in Oncology | Podcast | ASCO Publications

There is often a disconnect in toxicity assessment between what is reported on clinical trials as being “well tolerated” and the lived experience of taking a treatment for patients. Toxicity minimizin...

ascopubs.org

4 7

Angela Cochran @acochran12733.bsky.social · Jul 31

I don't agree with their peer review model, but the premise here is correct. There are rules of indexing and citation counting that are keeping journals from transforming into modern publication systems.

eLife @elife.bsky.social · Jul 31

“Journals and peer review are unlikely to change for the better if the companies that operate scientific indexes and citation databases continue to stifle innovation.”

Read our guest post in DORA: buff.ly/EGDbskH

1 1

Reposted by Angela Cochran

Scott Gottlieb, MD @scottgottliebmd.bsky.social · Jul 26

FDA’s cancer review team overseeing breast and gynecological products has lost about 1/3 of its medical review staff and the malignant heme group will lose about 2/3 of its medical review staff—all to voluntary resignations clustered among seasoned reviewers

insights.citeline.com/pink-sheet/a...

5 68 96

Reposted by Angela Cochran

Ashani Weeraratna @ashi-w.bsky.social · Jul 24

May the odds be ever in your favor.
4% payline at the NCI.

www.cancer.gov/grants-train...

Funding Policy - Research Grants

NCI funding policy for research project grant (RPG) awards reflects the funding goals of the institute, NIH, and HHS.

www.cancer.gov

4 9 33

Reposted by Angela Cochran

Nature @nature.com · Jul 14

In an unprecedented move, the NIH will soon disinvite dozens of scientists who were about to take positions on advisory councils that make final decisions on grant applications for the US agency, Nature has learnt.

go.nature.com/3TEw7GN

Exclusive: NIH to dismiss dozens of grant reviewers to align with Trump priorities

The move would undo years of work, leaving advisory councils understaffed, and without the full expertise needed for reviews.

go.nature.com

1 32 45

Angela Cochran @acochran12733.bsky.social · Jul 13

Can the next governor replace those people on the board? Seems it’s in Virginia residents best interest to have a world class public institution.

Angela Cochran @acochran12733.bsky.social · Jul 13

Agree. At least a decade of pushing our kids to STEM only. Result: few can critically read or write, entry level computer science/coding jobs were the 1st to get cut with AI, decrease in kids wanting to be physicians.

Glen O'Hara @gsoh31.bsky.social · Jul 13

Decades of mechanistic talk about university degrees as if they were bundles of 'skills' and 'prep' are about to be proved completely wrong (obviously). Want to get a real boost? Do History or English.

2

Reposted by Angela Cochran

Richard Van Noorden @richvn.bsky.social · Jul 11

Yep. Prestige costs money to create (literally: highly-selective journals are more expensive to run in part because of their selectivity, not to mention their staff). And, if gold OA is to be the model, then author or their funders are agreeing to pay per paper for that prestige.

1 3

Reposted by Angela Cochran

Julie Gralow @jrgralow.bsky.social · Jul 3

We have life saving cancer drugs and life threatening shortages. See our new op ed with potential solutions in @jco-asco.bsky.social

@lymphomadoc.bsky.social
@ascocancer.bsky.social

ascopubs.org/doi/10.1200/...

1 4

Reposted by Angela Cochran

Mandi Lindner @mandilindner.bsky.social · Jun 23

There's also a helpful criticism here that, if we have to constantly and meticulously double check the work of AI then is it a tool that really saves us time and effort? And, given that cost/benefit ratio, what are the actual use cases that make using it worthwhile?

1 1 9

Reposted by Angela Cochran

American Society of Clinical Oncology @ascocancer.bsky.social · May 30

‼️ #ASCO25 simultaneous publication by Jacobs et al: 

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

4 4

Reposted by Angela Cochran

American Society of Clinical Oncology @ascocancer.bsky.social · May 30

For breaking news and expert analysis during #ASCO25, turn to #ASCODailyNews! During and after the Meeting, ASCO Daily News has coverage of all the practice-changing research being presented. Bookmark us now: dailynews.ascopubs.org/meetings/asc... #oncsky

4 8

Reposted by Angela Cochran

Tatiana Prowell, MD @tmprowell.bsky.social · May 30

The @ascocancer.bsky.social Ed Book is the highest-quality, peer-reviewed, FREE #oncology #MedEd ever. Whether or not you’re at #ASCO25, don’t miss this resource, #OncSky #MedSky, #MedStudentSky! Drop a 📌 in the comments to bookmark the link for later.

ascopubs.org/toc/edbk/cur...

#OncoAlert

1 6 23

Angela Cochran @acochran12733.bsky.social · May 23

Don't miss it! #ASCODailyNews has your exclusive advanced coverage of important abstracts being presented at #ASCOAM dailynews.ascopubs.org/meetings/asc...

ASCO Annual Meeting | ASCO Daily News

The ASCO Annual Meeting is the Society's yearly gathering where oncologists unveil their latest clinical research, and ASCO Daily News has you covered before, during, and after the Meeting with in-dep...

dailynews.ascopubs.org

Reposted by Angela Cochran

American Society of Clinical Oncology @ascocancer.bsky.social · May 21

Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com

ASCO and Google create ‘walled garden’ AI tool for doctors to query group’s guidelines

ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without extraneous information.

www.statnews.com

2 3

Angela Cochran @acochran12733.bsky.social · May 23

Exciting news! Making ASCO expert, evidence-based treatment guidelines easier than ever to access.

American Society of Clinical Oncology @ascocancer.bsky.social · May 22

The ASCO Guidelines Assistant is built for how oncologists work today. Powered by AI and developed in partnership with Google Cloud, it delivers fast, evidence-based answers drawn exclusively from ASCO’s clinical practice guidelines.

Explore More: brnw.ch/21wSQGp

3

Angela Cochran @acochran12733.bsky.social · May 23

The first of many simultaneous publications out today in #JCOGO. More to come! #ASCO25

American Society of Clinical Oncology @ascocancer.bsky.social · May 22

‼️ #ASCO25 simultaneous publication by Tolani et al: 

Development and Validation of An Adapted Tool to Measure Health-Related Social Needs for The Prostate Cancer Population in Nigeria.

Read full article: brnw.ch/21wSRt9

2

Reposted by Angela Cochran

Jame Abraham, MD, FACP @jameabraham.bsky.social · May 13

Excellent review article by @ptarantinomd.bsky.social on redefining Her-2 testing @ethicsdoctorp.bsky.social @acochran12733.bsky.social ascopubs.org/doi/10.1200/... @oncoalert.bsky.social

2 2

Reposted by Angela Cochran

Jame Abraham, MD, FACP @jameabraham.bsky.social · Apr 19

Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social

4 7

Angela Cochran @acochran12733.bsky.social · Apr 17

So condescending. If it has no value in training then the resulting model is equally lacking in value.

1

Reposted by Angela Cochran

Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · Apr 17

Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice

ascopubs.org

1 3